Complete lack of
transcription factor PDX-1 leads to pancreatic agenesis, whereas heterozygosity for PDX-1 mutations has been recently noted in some individuals with
maturity-onset diabetes of the young (
MODY) and in some individuals with
type 2 diabetes. To determine how alterations in PDX-1 affect islet function, we examined insulin secretion and islet physiology in mice with one PDX-1 allele inactivated. PDX-1(+/-) mice had a normal fasting
blood glucose and pancreatic
insulin content but had
impaired glucose tolerance and secreted less
insulin during
glucose tolerance testing. The expression of PDX-1 and
glucose transporter 2 in islets from PDX-1(+/-) mice was reduced to 68 and 55%, respectively, whereas
glucokinase expression was not significantly altered.
NAD(P)H generation in response to
glucose was reduced by 30% in PDX-1(+/-) mice. The in situ perfused pancreas of PDX-1(+/-) mice secreted about 45% less
insulin when stimulated with 16.7 mm
glucose. The K(m) for
insulin release was similar in wild type and PDX-1(+/-) mice. Insulin secretion in response to 20 mm
arginine was unchanged; the response to 10 nm
glucagon-like peptide-1 was slightly increased. However,
insulin secretory responses to 10 mm
2-ketoisocaproate and 20 mm KCl were significantly reduced (by 61 and 66%, respectively). These results indicate that a modest reduction in PDX-1 impairs several events in
glucose-stimulated insulin secretion (such as
NAD(P)H generation, mitochondrial function, and/or mobilization of intracellular Ca(2+)) and that PDX-1 is important for normal function of adult pancreatic islets.